Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AI-assisted lifestyle intervention vs low-dose tirzepatide for weight loss maintenance in overweight/obese type 2 diabetes
ChiCTR2500112320Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of tirzepatide in type 2 diabetes mellitus (T2DM), Overweight and obesity (2 arms), sponsored by Union Hospital. Primary endpoint: Weight. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)Overweightobesity
Beyond the preview
Go deeper on ChiCTR2500112320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112320.